global cancer vaccine partnering 2010-2015: deal trends, players, financials and forecasts
TRANSCRIPT
www.MarketResearchReports.com
Global Cancer Vaccine
Partnering 2010-2015: Deal trends,
players, financials and
forecasts
Category : Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: July 1, 2015
Number of Pages: 336
Geography Coverage: Global
Available Format: PDF
Price For Single User License: USD 1,995
Price For Site User License: USD 5,995
Price For Global User License: USD 9,995
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
Global Cancer Vaccine (GCV) Partnering 2010-2015 report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides an understanding and analysis of how and why companies enter cancer vaccine partnering deals.
The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology.
www.MarketResearchReports.com
Key Findings:
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
The report takes readers through the comprehensive cancer vaccine deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering cancer vaccine partnering deals.
www.MarketResearchReports.com
Key Findings: Continue…
The report presents average financial deal terms values for cancer vaccine deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
The middle section of the report explores the leaders in the cancer vaccine partnering field; both the leading deal values and leading players are reported allowing readers to see who is succeeding in this growing market.
This chapter also looks at the contributions by the big pharma and big biotech companies of the world in terms of deals made.
www.MarketResearchReports.com
GCV Partnering 2010-2015 includes:
Trends in cancer vaccine dealmaking in the biopharma industry since 2010
Analysis of cancer vaccine deal structure
Access to headline, upfront, milestone and royalty data
Access to over 150 cancer vaccine deal records
The leading cancer vaccine deals by value since 2010
www.MarketResearchReports.com
Benefits:
In-depth understanding of cancer vaccine deal trends since 2010
Access to headline, upfront, milestone and royalty data
Acces to the structure of cancer vaccine agreements with numerous real life case studies
Comprehensive access to over 150 actual cancer vaccine deals entered into by the world’s biopharma companies, together with real world clause examples
Full listing of cancer vaccine deals by company A-Z, deal value, phase of development, deal type, and therapy focus
Identify leading cancer vaccine deals by value since 2010
www.MarketResearchReports.com
Benefits: Continue…
Identify the most active cancer vaccine dealmakers since 2010
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies
www.MarketResearchReports.com
Report Coverage:
1. Executive Summary
2. Introduction
3. Trends in cancer vaccine dealmaking
4. Average financial deal terms for cancer vaccine partnering
5. Leading cancer vaccine deals
6. Cancer vaccine dealmaking contracts directory
7. Cancer vaccine dealmaking by specific therapy type
8. Cancer vaccine dealmaking by specific technology type
For more details regarding Report coverage see the last slideAll logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Report Coverage: Continues…
9. Future trends and companies in cancer vaccine deal making
10. Appendices
11. Partnering resource center
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://mrr.cm/4E6
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)